Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation
- PMID: 15970000
- DOI: 10.1016/s1472-6483(10)61115-7
Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation
Abstract
During the early follicular phase in the menstrual cycle, antral follicle sizes are often markedly heterogeneous. These follicular size discrepancies may, at least in part, result from the early exposure of FSH-sensitive follicles to gradient FSH concentrations during the preceding luteal phase. In addition, they potentially affect the results of ovarian stimulation. Indeed, pre-existing follicle size discrepancies may encumber coordinated follicular growth during ovarian stimulation, thereby reducing the number of follicles that reach maturation at once. To investigate this issue, three clinical studies were conducted to test the hypothesis that luteal FSH suppression could coordinate follicular growth. First, luteal FSH concentrations were artificially lowered by administering physiological oestradiol doses and measured follicular characteristics on the subsequent day 3. Second, it was verified whether luteal oestradiol administration could promote the coordination of follicular growth during ovarian stimulation and improve its results. Third, the effects of premenstrual gonadotrophin-releasing hormone (GnRH) antagonist administration on follicular characteristics were assessed during the early follicular phase. The results showed that luteal FSH suppression by either oestradiol or GnRH antagonist administration reduces the size and improves the homogeneity of early antral follicles during the early follicular phase, an effect that persists during ovarian stimulation. Coordination of follicular development may optimize ovarian response to short GnRH agonist and antagonist protocols, and constitutes an attractive approach to improving their outcome.
Similar articles
-
Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation.Semin Reprod Med. 2005 Nov;23(4):354-62. doi: 10.1055/s-2005-923393. Semin Reprod Med. 2005. PMID: 16317624 Review.
-
Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation.Fertil Steril. 2004 Jun;81(6):1554-9. doi: 10.1016/j.fertnstert.2003.11.037. Fertil Steril. 2004. PMID: 15193476
-
[Coordination of follicle antrum: from luteal estradiol to the premenstrual antagonist].J Gynecol Obstet Biol Reprod (Paris). 2004 Oct;33(6 Pt 2):3S21-3. J Gynecol Obstet Biol Reprod (Paris). 2004. PMID: 15643681 French.
-
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).Fertil Steril. 2001 Apr;75(4):688-93. doi: 10.1016/s0015-0282(00)01789-1. Fertil Steril. 2001. PMID: 11287020 Clinical Trial.
-
[The programming of IVF cycles with antagonists].J Gynecol Obstet Biol Reprod (Paris). 2004 Oct;33(6 Pt 2):3S19-20. J Gynecol Obstet Biol Reprod (Paris). 2004. PMID: 15643680 Review. French.
Cited by
-
LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol.Front Endocrinol (Lausanne). 2024 Dec 23;15:1521734. doi: 10.3389/fendo.2024.1521734. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39764246 Free PMC article.
-
Tadalafil for Endometrial Growth in Clomiphene Citrate stimulated cycles in an IUI programma: A pilot study.Facts Views Vis Obgyn. 2015 Dec 28;7(4):231-237. Facts Views Vis Obgyn. 2015. PMID: 27729968 Free PMC article.
-
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.Reprod Biol Endocrinol. 2011 Jun 21;9:82. doi: 10.1186/1477-7827-9-82. Reprod Biol Endocrinol. 2011. PMID: 21693025 Free PMC article.
-
GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI.Clin Exp Reprod Med. 2011 Dec;38(4):228-33. doi: 10.5653/cerm.2011.38.4.228. Epub 2011 Dec 31. Clin Exp Reprod Med. 2011. PMID: 22384447 Free PMC article.
-
Effect of the degree of follicular diameter ≥18mm differentiation on the day of hCG administration to the outcome of controlled ovarian hyperstimulation (COH).Front Endocrinol (Lausanne). 2024 Jun 28;15:1414213. doi: 10.3389/fendo.2024.1414213. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39006360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical